{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T18:55:41Z","timestamp":1790276141309,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,9,2]],"date-time":"2016-09-02T00:00:00Z","timestamp":1472774400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Foundation of Clinical Chemistry Research"},{"DOI":"10.13039\/100010135","name":"Finska L\u00e4kares\u00e4llskapet","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100010135","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006383","name":"Cancer Society of Finland","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006383","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s00280-016-3150-3","type":"journal-article","created":{"date-parts":[[2016,9,2]],"date-time":"2016-09-02T06:33:43Z","timestamp":1472798023000},"page":"863-874","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Intestinal permeability to iohexol as an in vivo marker of chemotherapy-induced gastrointestinal toxicity in Sprague\u2013Dawley rats"],"prefix":"10.1007","volume":"78","author":[{"given":"Richard A.","family":"Forsg\u00e5rd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riitta","family":"Korpela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reetta","family":"Holma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jere","family":"Lind\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Frias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Spillmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"\u00d6sterlund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,2]]},"reference":[{"key":"3150_CR1","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1136\/gutjnl-2011-300563","volume":"61","author":"HJN Andreyev","year":"2012","unstructured":"Andreyev HJN, Davidson SE, Gillespie C et al (2012) Practice guidance on the management of acute and chronic gastrointestinal problems arising as a result of treatment for cancer. Gut 61:179\u2013192. doi: 10.1136\/gutjnl-2011-300563","journal-title":"Gut"},{"key":"3150_CR2","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/SPC.0b013e32835f3e8c","volume":"7","author":"HR Wardill","year":"2013","unstructured":"Wardill HR, Bowen JM (2013) Chemotherapy-induced mucosal barrier dysfunction: an updated review on the role of intestinal tight junctions. Curr Opin Support Palliat Care 7:155\u2013161. doi: 10.1097\/SPC.0b013e32835f3e8c","journal-title":"Curr Opin Support Palliat Care"},{"key":"3150_CR3","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/nrc1318","volume":"4","author":"ST Sonis","year":"2004","unstructured":"Sonis ST (2004) The pathobiology of mucositis. Nat Rev Cancer 4:277\u2013284. doi: 10.1038\/nrc1318","journal-title":"Nat Rev Cancer"},{"key":"3150_CR4","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1042\/cs0920385","volume":"92","author":"DM Keefe","year":"1997","unstructured":"Keefe DM, Cummins AG, Dale BM et al (1997) Effect of high-dose chemotherapy on intestinal permeability in humans. Clin Sci Lond Engl 92:385\u2013389","journal-title":"Clin Sci Lond Engl"},{"key":"3150_CR5","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/1471-2407-13-56","volume":"13","author":"F Russo","year":"2013","unstructured":"Russo F, Linsalata M, Clemente C et al (2013) The effects of fluorouracil, epirubicin, and cyclophosphamide (FEC60) on the intestinal barrier function and gut peptides in breast cancer patients: an observational study. BMC Cancer 13:56. doi: 10.1186\/1471-2407-13-56","journal-title":"BMC Cancer"},{"key":"3150_CR6","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.clnu.2006.07.003","volume":"26","author":"K Choi","year":"2007","unstructured":"Choi K, Lee SS, Oh SJ et al (2007) The effect of oral glutamine on 5-fluorouracil\/leucovorin-induced mucositis\/stomatitis assessed by intestinal permeability test. Clin Nutr Edinb Scotl 26:57\u201362. doi: 10.1016\/j.clnu.2006.07.003","journal-title":"Clin Nutr Edinb Scotl"},{"key":"3150_CR7","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/1471-2407-7-155","volume":"7","author":"B Melichar","year":"2007","unstructured":"Melichar B, Hyspler R, Dragounov\u00e1 E et al (2007) Gastrointestinal permeability in ovarian cancer and breast cancer patients treated with paclitaxel and platinum. BMC Cancer 7:155. doi: 10.1186\/1471-2407-7-155","journal-title":"BMC Cancer"},{"key":"3150_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jaci.2009.05.038","volume":"124","author":"KR Groschwitz","year":"2009","unstructured":"Groschwitz KR, Hogan SP (2009) Intestinal barrier function: molecular regulation and disease pathogenesis. J Allergy Clin Immunol 124:3\u201320. doi: 10.1016\/j.jaci.2009.05.038","journal-title":"J Allergy Clin Immunol"},{"key":"3150_CR9","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1136\/gut.2005.085373","volume":"55","author":"MC Arrieta","year":"2006","unstructured":"Arrieta MC, Bistritz L, Meddings JB (2006) Alterations in intestinal permeability. Gut 55:1512\u20131520. doi: 10.1136\/gut.2005.085373","journal-title":"Gut"},{"key":"3150_CR10","first-page":"1","volume":"40","author":"R Frias","year":"2014","unstructured":"Frias R, Ouwehand AC, Jaakkola U-M et al (2014) An in vivo permeability test protocol using iohexol to reduce and refine the use of laboratory rats in intestinal damage assessment. Scand J Lab Anim Sci 40:1\u20136","journal-title":"Scand J Lab Anim Sci"},{"key":"3150_CR11","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1080\/00365510050216420","volume":"60","author":"L Halme","year":"2000","unstructured":"Halme L, Turunen U, Tuominen J et al (2000) Comparison of iohexol and lactulose-mannitol tests as markers of disease activity in patients with inflammatory bowel disease. Scand J Clin Lab Invest 60:695\u2013701","journal-title":"Scand J Clin Lab Invest"},{"key":"3150_CR12","first-page":"237","volume":"34","author":"L Halme","year":"1993","unstructured":"Halme L, Edgren J, von Smitten K, Linden H (1993) Increased urinary excretion of iohexol after enteral administration in patients with ileal Crohn\u2019s disease. A new test for disease activity. Acta Radiol Stockh Swed 34:237\u2013241","journal-title":"Acta Radiol Stockh Swed"},{"key":"3150_CR13","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3109\/00365529709000185","volume":"32","author":"L Halme","year":"1997","unstructured":"Halme L, Edgren J, Turpeinen U et al (1997) Urinary excretion of iohexol as a marker of disease activity in patients with inflammatory bowel disease. Scand J Gastroenterol 32:148\u2013152","journal-title":"Scand J Gastroenterol"},{"key":"3150_CR14","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.tvjl.2011.04.024","volume":"192","author":"R Frias","year":"2012","unstructured":"Frias R, Strube K, Ternes W et al (2012) Comparison of 51 chromium-labeled ethylenediamine tetra-acetic acid and iohexol as blood markers for intestinal permeability testing in Beagle dogs. Vet J Lond Engl 192:123\u2013125. doi: 10.1016\/j.tvjl.2011.04.024","journal-title":"Vet J Lond Engl"},{"key":"3150_CR15","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1177\/0284185195036S39930","volume":"399","author":"R Andersen","year":"1995","unstructured":"Andersen R, Laerum F (1995) Intestinal permeability measurements\u2014a new application for water soluble contrast media? Acta Radiol Suppl 399:247\u2013252","journal-title":"Acta Radiol Suppl"},{"key":"3150_CR16","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/j.cgh.2012.08.012","volume":"10","author":"A Fasano","year":"2012","unstructured":"Fasano A (2012) Intestinal permeability and its regulation by zonulin: diagnostic and therapeutic implications. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc 10:1096\u20131100. doi: 10.1016\/j.cgh.2012.08.012","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"3150_CR17","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ghir.2004.12.002","volume":"15","author":"JC Cool","year":"2005","unstructured":"Cool JC, Dyer JL, Xian CJ et al (2005) Pre-treatment with insulin-like growth factor-I partially ameliorates 5-fluorouracil-induced intestinal mucositis in rats. Growth Horm IGF Res Off J Growth Horm Res Soc Int IGF Res Soc 15:72\u201382. doi: 10.1016\/j.ghir.2004.12.002","journal-title":"Growth Horm IGF Res Off J Growth Horm Res Soc Int IGF Res Soc"},{"key":"3150_CR18","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/CAD.0000000000000142","volume":"26","author":"X Wang","year":"2015","unstructured":"Wang X, Gao J, Qian L et al (2015) Exogenous IL-1Ra attenuates intestinal mucositis induced by oxaliplatin and 5-fluorouracil through suppression of p53-dependent apoptosis. Anticancer Drugs 26:35\u201345. doi: 10.1097\/CAD.0000000000000142","journal-title":"Anticancer Drugs"},{"key":"3150_CR19","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1159\/000107458","volume":"53","author":"RJ Gibson","year":"2007","unstructured":"Gibson RJ, Bowen JM, Alvarez E et al (2007) Establishment of a single-dose irinotecan model of gastrointestinal mucositis. Chemotherapy 53:360\u2013369. doi: 10.1159\/000107458","journal-title":"Chemotherapy"},{"key":"3150_CR20","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1046\/j.1440-1746.2003.03136.x","volume":"18","author":"RJ Gibson","year":"2003","unstructured":"Gibson RJ, Bowen JM, Inglis MRB et al (2003) Irinotecan causes severe small intestinal damage, as well as colonic damage, in the rat with implanted breast cancer. J Gastroenterol Hepatol 18:1095\u20131100","journal-title":"J Gastroenterol Hepatol"},{"issue":"Suppl 1","key":"3150_CR21","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.jcpa.2008.01.001","volume":"138","author":"MJ Day","year":"2008","unstructured":"Day MJ, Bilzer T, Mansell J et al (2008) Histopathological standards for the diagnosis of gastrointestinal inflammation in endoscopic biopsy samples from the dog and cat: a report from the World Small Animal Veterinary Association Gastrointestinal Standardization Group. J Comp Pathol 138(Suppl 1):S1\u2013S43. doi: 10.1016\/j.jcpa.2008.01.001","journal-title":"J Comp Pathol"},{"key":"3150_CR22","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/s00280-001-0414-2","volume":"49","author":"B Fazeny-D\u00f6rner","year":"2002","unstructured":"Fazeny-D\u00f6rner B, Veitl M, Wenzel C et al (2002) Alterations in intestinal permeability following the intensified polydrug-chemotherapy IFADIC (ifosfamide, Adriamycin, dacarbazine). Cancer Chemother Pharmacol 49:294\u2013298. doi: 10.1007\/s00280-001-0414-2","journal-title":"Cancer Chemother Pharmacol"},{"key":"3150_CR23","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/00004836-200103000-00010","volume":"32","author":"B Daniele","year":"2001","unstructured":"Daniele B, Secondulfo M, De Vivo R et al (2001) Effect of chemotherapy with 5-fluorouracil on intestinal permeability and absorption in patients with advanced colorectal cancer. J Clin Gastroenterol 32:228\u2013230","journal-title":"J Clin Gastroenterol"},{"key":"3150_CR24","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1097\/COC.0b013e318174dbb9","volume":"31","author":"B Melichar","year":"2008","unstructured":"Melichar B, Dvor\u00e1k J, Krcmov\u00e1 L et al (2008) Intestinal permeability and vitamin A absorption in patients with chemotherapy-induced diarrhea. Am J Clin Oncol 31:580\u2013584. doi: 10.1097\/COC.0b013e318174dbb9","journal-title":"Am J Clin Oncol"},{"key":"3150_CR25","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/00004836-200103000-00010","volume":"32","author":"B Daniele","year":"2001","unstructured":"Daniele B, Secondulfo M, De Vivo R et al (2001) Effect of chemotherapy with 5-fluorouracil on intestinal permeability and absorption in patients with advanced colorectal cancer. J Clin Gastroenterol 32:228\u2013230","journal-title":"J Clin Gastroenterol"},{"key":"3150_CR26","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/nri2653","volume":"9","author":"JR Turner","year":"2009","unstructured":"Turner JR (2009) Intestinal mucosal barrier function in health and disease. Nat Rev Immunol 9:799\u2013809. doi: 10.1038\/nri2653","journal-title":"Nat Rev Immunol"},{"key":"3150_CR27","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.2337\/db05-1593","volume":"55","author":"A Sapone","year":"2006","unstructured":"Sapone A, de Magistris L, Pietzak M et al (2006) Zonulin upregulation is associated with increased gut permeability in subjects with type 1 diabetes and their relatives. Diabetes 55:1443\u20131449","journal-title":"Diabetes"},{"key":"3150_CR28","doi-asserted-by":"publisher","first-page":"236","DOI":"10.4161\/cbt.27222","volume":"15","author":"HR Wardill","year":"2014","unstructured":"Wardill HR, Bowen JM, Al-Dasooqi N et al (2014) Irinotecan disrupts tight junction proteins within the gut. Cancer Biol Ther 15:236\u2013244. doi: 10.4161\/cbt.27222","journal-title":"Cancer Biol Ther"},{"key":"3150_CR29","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.jss.2010.10.003","volume":"173","author":"T Nakao","year":"2012","unstructured":"Nakao T, Kurita N, Komatsu M et al (2012) Irinotecan injures tight junction and causes bacterial translocation in rat. J Surg Res 173:341\u2013347. doi: 10.1016\/j.jss.2010.10.003","journal-title":"J Surg Res"},{"key":"3150_CR30","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12944-015-0052-z","volume":"14","author":"SV Generoso de","year":"2015","unstructured":"de Generoso SV, Rodrigues NM, Trindade LM et al (2015) Dietary supplementation with omega-3 fatty acid attenuates 5-fluorouracil induced mucositis in mice. Lipids Health Dis 14:54. doi: 10.1186\/s12944-015-0052-z","journal-title":"Lipids Health Dis"},{"key":"3150_CR31","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1477-5751-13-6","volume":"13","author":"TU Maioli","year":"2014","unstructured":"Maioli TU, de Melo Silva B, Dias MN et al (2014) Pretreatment with Saccharomyces boulardii does not prevent the experimental mucositis in Swiss mice. J Negat Results Biomed 13:6. doi: 10.1186\/1477-5751-13-6","journal-title":"J Negat Results Biomed"},{"key":"3150_CR32","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s00280-014-2663-x","volume":"75","author":"PFC Justino","year":"2015","unstructured":"Justino PFC, Melo LFM, Nogueira AF et al (2015) Regulatory role of Lactobacillus acidophilus on inflammation and gastric dysmotility in intestinal mucositis induced by 5-fluorouracil in mice. Cancer Chemother Pharmacol 75:559\u2013567. doi: 10.1007\/s00280-014-2663-x","journal-title":"Cancer Chemother Pharmacol"},{"key":"3150_CR33","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s002800050818","volume":"42","author":"K Takasuna","year":"1998","unstructured":"Takasuna K, Hagiwara T, Hirohashi M et al (1998) Inhibition of intestinal microflora beta-glucuronidase modifies the distribution of the active metabolite of the antitumor agent, irinotecan hydrochloride (CPT-11) in rats. Cancer Chemother Pharmacol 42:280\u2013286","journal-title":"Cancer Chemother Pharmacol"},{"key":"3150_CR34","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.ctrv.2007.03.001","volume":"33","author":"RM Logan","year":"2007","unstructured":"Logan RM, Stringer AM, Bowen JM et al (2007) The role of pro-inflammatory cytokines in cancer treatment-induced alimentary tract mucositis: pathobiology, animal models and cytotoxic drugs. Cancer Treat Rev 33:448\u2013460. doi: 10.1016\/j.ctrv.2007.03.001","journal-title":"Cancer Treat Rev"},{"key":"3150_CR35","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00280-008-0732-8","volume":"63","author":"RM Logan","year":"2009","unstructured":"Logan RM, Stringer AM, Bowen JM et al (2009) Is the pathobiology of chemotherapy-induced alimentary tract mucositis influenced by the type of mucotoxic drug administered? Cancer Chemother Pharmacol 63:239\u2013251. doi: 10.1007\/s00280-008-0732-8","journal-title":"Cancer Chemother Pharmacol"},{"key":"3150_CR36","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s00280-007-0534-4","volume":"61","author":"MLP Melo","year":"2008","unstructured":"Melo MLP, Brito GAC, Soares RC et al (2008) Role of cytokines (TNF-alpha, IL-1beta and KC) in the pathogenesis of CPT-11-induced intestinal mucositis in mice: effect of pentoxifylline and thalidomide. Cancer Chemother Pharmacol 61:775\u2013784. doi: 10.1007\/s00280-007-0534-4","journal-title":"Cancer Chemother Pharmacol"},{"key":"3150_CR37","doi-asserted-by":"publisher","first-page":"802","DOI":"10.18632\/oncotarget.1773","volume":"5","author":"BM Kojouharov","year":"2014","unstructured":"Kojouharov BM, Brackett CM, Veith JM et al. (2014) Toll-like receptor-5 agonist Entolimod broadens the therapeutic window of 5-fluorouracil by reducing its toxicity to normal tissues in mice. Oncotarget 5:802\u2013814. doi: 10.18632\/oncotarget.1773","journal-title":"Oncotarget"},{"key":"3150_CR38","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1111\/bph.12584","volume":"171","author":"RCP Lima-J\u00fanior","year":"2014","unstructured":"Lima-J\u00fanior RCP, Freitas HC, Wong DVT et al (2014) Targeted inhibition of IL-18 attenuates irinotecan-induced intestinal mucositis in mice. Br J Pharmacol 171:2335\u20132350. doi: 10.1111\/bph.12584","journal-title":"Br J Pharmacol"},{"key":"3150_CR39","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s00018-012-1070-x","volume":"70","author":"T Suzuki","year":"2013","unstructured":"Suzuki T (2013) Regulation of intestinal epithelial permeability by tight junctions. Cell Mol Life Sci CMLS 70:631\u2013659. doi: 10.1007\/s00018-012-1070-x","journal-title":"Cell Mol Life Sci CMLS"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-016-3150-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-016-3150-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-016-3150-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T00:23:54Z","timestamp":1568334234000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-016-3150-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,2]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["3150"],"URL":"https:\/\/doi.org\/10.1007\/s00280-016-3150-3","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,2]]}}}